Company
Turnstone Biologics Corp. (0001764974)
Standardized SEC financial data for Turnstone Biologics Corp. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001764974 · Biological Products, (No Diagnostic Substances).
Operating margin
-375.5%
Net margin
-366.9%
Revenue growth (YoY)
-73.7%
Return on equity
-225.1%
Free cash flow
-$67.7M
Current ratio
4.17×
EPS (diluted)
$-3.07
Ratios for fiscal year 2023, standardized from SEC filings.
Income statement
| USD | FY2022 | FY2023 | FY2024 |
|---|---|---|---|
| Revenue | $73.3M | $19.3M | — |
| R&D expense | $86.7M | $60.5M | $56.1M |
| SG&A expense | $18.2M | $17.8M |
Balance sheet
| USD | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
| Cash & equivalents | $123.8M | $35.1M | $94.8M | $29.0M |
| Total current assets | — | $98.0M | $102.6M | $34.2M |
Cash flow
| USD | FY2022 | FY2023 | FY2024 |
|---|---|---|---|
| Operating cash flow | -$71.1M | -$66.2M | -$67.4M |
| Capital expenditures | $5.2M | $1.2M | $229K |
| Free cash flow | -$76.2M | -$67.4M |
Get 0001764974 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001764974/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001764974/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"